-
Mashup Score: 3World's largest and most diverse skin and hair health study launches by L'Oréal and Verily | Verily Life Sciences - 10 month(s) ago
The ‘My Skin & Hair Journey’ registry now open for enrollment, seeking self-identifying women participants for U.S. cohort
Source: verily.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Bio Eats World: AI, Innovation, and Regulatory Insights with Amy Abernethy on Apple Podcasts - 11 month(s) ago
Show Bio Eats World, Ep AI, Innovation, and Regulatory Insights with Amy Abernethy – 27 Jun 2023
Source: Apple PodcastsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2ChatGPT Gaining Foothold in Drug Development, Clinical Trials - 11 month(s) ago
Gaurav Sharma says ChatGPT is already helping in the search for new medicines, cutting the time it takes to identify molecules for potential new drugs from a month down to a week.
Source: bnanews.bna.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 6Time for real-world health data to become routine - 1 year(s) ago
Real-world data reflect the diversity and lived experiences of individuals and so should be a central pillar of clinical research and care.
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0DIA/FDA Biostatistics Industry and Regulator Forum - 1 year(s) ago
Biostatistics Industry and Regulator Forum
Source: www.diaglobal.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1The Success of Your Tech Deployment Depends On A Role You’ve Probably Never Heard Of - TimmermanReport.com - 1 year(s) ago
The success or failure of many technology platforms — including in particular health tech platforms — rests with a largely obscure role of outsized importance: the “solutions engineer.” The role itself goes by many names. Back when I was at DNAnexus in the mid-2010s, this role was called “Solutions Scientist.” Others call it “Forward-Deployed Engineer”… Read More
Source: Timmerman ReportCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4
Evidence generation has undeniably grown beyond traditional trials to include a number of other sources and continues to evolve. Amy Abernethy, former FDA deputy chief, sees a future in which therapies are approved earlier and continually evaluated with high-quality data, but it will be on industry to connect the dots and build a strong foundation to make this a reality, she says.
Source: cms.centerwatch.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3
The role that real-world evidence, and the data that feeds into it, play in the clinical trials arena is changing. For many years, drug developers and regulators have collected real-world data (RWD) on adverse events linked to newly approved medicines. However, this data has not played a significant role in developing or executing pre-approval clinical […]
Source: Inside Precision MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Amy Abernethy, President of Product Development and Chief Medical Officer of Verily - Sixth Street - 1 year(s) ago
PODCAST
Source: Sixth StreetCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
HLTH is turning 5! Join our reimagined must-attend event that will continue to build upon our commitment to transforming the next 10 years of healthcare. The entire healthcare ecosystem will be there.
Source: HLTHCategories: Hem/Oncs, Latest HeadlinesTweet
Together with @LOrealGroupe, we have launched My Skin & Hair Journey, a multi-year study for self-identifying women of all backgrounds. Thrilled to work together on this research effort to advance precision skin and hair health. https://t.co/QKcwsOnYrh https://t.co/wKULkCqFK6 https://t.co/qCCiYEUBYS